Department of Justice (DOJ) news from FierceHealthcare
News
New Jersey med school agrees to $8.3 million kickback settlement with DoJ
In yet another chapter of a history dogged by questions of corruption, the University of Medicine and Dentistry of New Jersey (UMDNJ) has agreed to pay the federal government $8.3 million to settle... Read more...
DOJ accepts GA hospitals' joint purchasing agreement
The U.S. Department of Justice has decided to offer no challenge to a proposal by two hospitals to enter into an exclusive joint purchasing agreement for some of their medical and surgical supplies.... Read more...
Pfizer pays $2.3B penalty for off-label drug marketing
Pfizer has agreed to pay a mammoth $3.2 billion penalty for marketing off-label uses of several of its drugs, a settlement which the U.S. Department of Justice has labeled the largest healthcare... Read more...
Iowa hospital pays $4.5M to settle excess compensation claims
An Iowa hospital has agreed to pay $4.5 million to settle with the federal government over charges that it used Medicare funds to pay physicians sweet salaries in exchange for their referrals. The... Read more...
American Hospital Association wants tougher reviews of health-plan mergers
The American Hospital Association--and the AMA, for that matter--isn't too happy with the rate of health plan mergers taking place in the country in recent years. Fighting such mergers hasn't been... Read more...
DoJ joins whistle-blower suit against Community Health Systems
The U.S. Department of Justice has joined a whistle-blower suit against Community Health Systems, which charges that three of the chain's New Mexico hospitals violated the False Claims Act. The... Read more...
Forest accused of hiding negative Celexa, Lexapro results
The U.S. Department of Justice has filed a complaint against Forest Laboratories, the maker of antidepressants Celexa and Lexapro, accusing it of being underhanded in how it disclosed its research.... Read more...
Lilly to pay $1.4B to settle Zyprexa marketing charges
For some time now, advocates for seniors have complained that anti-psychotic drugs were being used to chemically restrain demented patients, leaving them sedated and unaware. Now one drugmaker, Eli... Read more...
Rite Aid pays $5M to resolve Controlled Substances Act violations
Chain store giant Rite Aid Corp. and nine of its subsidiaries in eight states have agreed to pay $5 million to settle charges that the company violated provisions of the federal Controlled Substances... Read more...
Bayer settles 'cash for patients' allegations for $97.5 million
Bayer HealthCare has agreed to pay $97.5 million to settle charges that its diabetes care division paid suppliers to move patients over to Bayer products from competing ones. The company admitted no... Read more...
